Barry Ladizinski

2.7k total citations · 2 hit papers
72 papers, 1.6k citations indexed

About

Barry Ladizinski is a scholar working on Dermatology, Epidemiology and Surgery. According to data from OpenAlex, Barry Ladizinski has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Dermatology, 17 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Barry Ladizinski's work include Dermatology and Skin Diseases (18 papers), Drug-Induced Adverse Reactions (8 papers) and Allergic Rhinitis and Sensitization (8 papers). Barry Ladizinski is often cited by papers focused on Dermatology and Skin Diseases (18 papers), Drug-Induced Adverse Reactions (8 papers) and Allergic Rhinitis and Sensitization (8 papers). Barry Ladizinski collaborates with scholars based in United States, Canada and Germany. Barry Ladizinski's co-authors include Kachiu C. Lee, Nisha Mistry, Alvina D. Chu, Henrique D. Teixeira, Marjolein de Bruin‐Weller, Daniel G. Federman, Roopal V. Kundu, John Liu, Afsáneh Alavi and Peter Lio and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Barry Ladizinski

64 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

2021 305 citations Henrique D. Teixeira, Eric L. Simpson et al. JAMA Dermatology profile →
Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

2021 250 citations Kristian Reich, Henrique D. Teixeira et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barry Ladizinski United States	18	1.0k	467	277	250	169	72	1.6k
Andrea L. Zaenglein United States	22	1.7k 1.7×	352 0.8×	210 0.8×	174 0.7×	101 0.6×	114	2.2k
Vivian Y. Shi United States	32	2.3k 2.3×	738 1.6×	268 1.0×	322 1.3×	271 1.6×	250	3.2k
Paula Beattie United Kingdom	17	843 0.8×	396 0.8×	135 0.5×	183 0.7×	164 1.0×	26	1.2k
Yik Weng Yew Singapore	21	796 0.8×	423 0.9×	172 0.6×	223 0.9×	167 1.0×	100	1.5k
Lee T. Zane United States	21	1.2k 1.2×	605 1.3×	178 0.6×	243 1.0×	85 0.5×	50	1.8k
Maeve A. McAleer Ireland	18	851 0.8×	523 1.1×	96 0.3×	221 0.9×	216 1.3×	34	1.3k
TA Luger Germany	26	776 0.8×	273 0.6×	321 1.2×	171 0.7×	757 4.5×	68	2.0k
Andrzej Kaszuba Poland	22	980 1.0×	279 0.6×	538 1.9×	146 0.6×	796 4.7×	107	2.0k
Michael David Israel	20	790 0.8×	252 0.5×	301 1.1×	213 0.9×	480 2.8×	67	1.9k
Cataldo Patruno Italy	31	2.1k 2.1×	818 1.8×	416 1.5×	382 1.5×	619 3.7×	216	3.0k

Countries citing papers authored by Barry Ladizinski

Since Specialization

Citations

This map shows the geographic impact of Barry Ladizinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Ladizinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Ladizinski more than expected).

Fields of papers citing papers by Barry Ladizinski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Ladizinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Ladizinski. The network helps show where Barry Ladizinski may publish in the future.

Co-authorship network of co-authors of Barry Ladizinski

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Ladizinski. A scholar is included among the top collaborators of Barry Ladizinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Ladizinski. Barry Ladizinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simpson, Eric L., Vimal H. Prajapati, Yael A. Leshem, et al.. (2024). Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and Therapy. 14(5). 1127–1144. 3 indexed citations

Thyssen, Jacob P., David Rosmarin, Antonio Costanzo, et al.. (2024). Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study. Dermatology. 241(1). 1–9.

Kwatra, Shawn G., Peter Lio, Stephan Weidinger, et al.. (2023). Patient preferences for atopic dermatitis treatments: a discrete choice experiment. Journal of Dermatological Treatment. 34(1). 2222201–2222201. 11 indexed citations

Blauvelt, Andrew, Barry Ladizinski, Vimal H. Prajapati, et al.. (2023). Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up). Journal of the American Academy of Dermatology. 89(3). 478–485. 23 indexed citations

Guttman‐Yassky, Emma, Jacob P. Thyssen, Jonathan I. Silverberg, et al.. (2022). Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies. Journal of Allergy and Clinical Immunology. 151(1). 172–181. 43 indexed citations

Silverberg, Jonathan I., Marjolein de Bruin‐Weller, Thomas Bieber, et al.. (2021). Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results. Journal of Allergy and Clinical Immunology. 149(3). 977–987.e14. 76 indexed citations

Alavi, Afsáneh, R. Gary Sibbald, Barry Ladizinski, et al.. (2016). Wound-Related Allergic/Irritant Contact Dermatitis. Advances in Skin & Wound Care. 29(6). 278–286. 29 indexed citations

Ladizinski, Barry & Kachiu C. Lee. (2014). Infliximab-Induced Urticaria. Journal of Emergency Medicine. 46(5). 691–692. 2 indexed citations

Ladizinski, Barry, et al.. (2014). Acute Epstein-Barr Virus Infection and Human Immunodeficiency Virus Antibody Cross-reactivity. The American Journal of Medicine. 127(6). e9–e10. 3 indexed citations

10.

Ladizinski, Barry, et al.. (2014). Vanishing Lung Syndrome. New England Journal of Medicine. 370(9). e14–e14. 6 indexed citations

11.

Ladizinski, Barry & Daniel G. Federman. (2013). Approaching Erectile Dysfunction in Dermatology Patients. JAMA Dermatology. 149(7). 783–783. 2 indexed citations

12.

Ladizinski, Barry, et al.. (2013). Lips as Red as Blood: Areca Nut Lip Staining. JAMA Dermatology. 149(11). 1288–1288. 3 indexed citations

13.

Heller, Misha M., Jillian W. Wong, Eric S. Lee, et al.. (2013). Delusional infestations: clinical presentation, diagnosis and treatment. International Journal of Dermatology. 52(7). 775–783. 39 indexed citations

14.

Ladizinski, Barry & David J. Elpern. (2013). Dronaderone-induced phototoxicity.. PubMed. 12(8). 946–7. 8 indexed citations

15.

Ladizinski, Barry, et al.. (2013). Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy.. PubMed. 12(2). e20–4. 2 indexed citations

16.

Ladizinski, Barry, et al.. (2013). A 4-Day-Old Neonate With a Widespread Vesicular Rash. JAMA. 310(9). 971–971. 1 indexed citations

17.

Ladizinski, Barry, et al.. (2013). Pigmented concealing powders for the hair loss patient. Journal of Cosmetic Dermatology. 12(4). 322–324. 5 indexed citations

18.

Lee, Kachiu C., Barry Ladizinski, & Daniel G. Federman. (2012). Complications Associated With Use of Levamisole-Contaminated Cocaine: An Emerging Public Health Challenge. Mayo Clinic Proceedings. 87(6). 581–586. 103 indexed citations

19.

Lee, Kachiu C. & Barry Ladizinski. (2012). Dyshidrotic eczema following intravenous immunoglobulin treatment. Canadian Medical Association Journal. 185(11). E530–E530. 3 indexed citations

20.

Ladizinski, Barry, Nisha Mistry, & Roopal V. Kundu. (2010). Widespread Use of Toxic Skin Lightening Compounds: Medical and Psychosocial Aspects. Dermatologic Clinics. 29(1). 111–123. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact